We continue to see patients and ensure they receive high-quality cancer care in a safe environment.
Review our enhanced safety measures. Learn about our appointment types or call 913-588-1227 to schedule.
Cancer Types & Treatments
NCI CANCER CENTER
Patients & Caregivers
Becoming Our Patient
Cancer Education
Tools & Resources
For Caregivers
Support Services
Survivorship & Hope
Clinical Trials
Find a Clinical Trial
Reasons to Participate
How to Join a Clinical Trial
For Professionals & Partners
Research
Areas of Research
Research Programs
Research That Transforms
Give Back to Research
Training & Education
Faculty Development
Graduate Education
Fellowship & Residency
High School & Undergraduate
Outreach & Prevention
Outreach & Community Initiatives
Prevention & Risk Reduction
Cancer Awareness
Kansas City, Kan. ― The University of Kansas Health System now offers radioembolization, also known as Y-90, as an outpatient procedure at The University of Kansas Hospital in Overland Park. Our fellowship-trained interventional radiologists speciali...
U.S. News & World Report released its 2020-21 Best Hospitals rankings on July 28. The cancer program at The University of Kansas Hospital is recognized among the top 10% of all hospitals in the nation. U.S. News evaluates hospitals on a series of a...
Honor recognizes exceptional service to the field of radiation oncology and cancer care
Graduate student Matthew Schaich forges ahead with research efforts, career aspirations, despite added challenges of pandemic.
The meeting featured a variety of sessions including a Clinical Plenary session, led by Weijing Sun, MD, director of Medical Oncology.
Task force is guided by strategic priorities, include addressing areas of unmet clinical need, unanswered clinical questions and potential new approaches to disease treatment.
More than 42,750 people from 138 countries attended this year’s American Society of Clinical Oncology (ASCO) annual meeting. Held virtually for the first time ever, the meeting featured 2,600 faculty and speakers and 5,300 abstracts delivering the latest news in cancer research. Members of The University of Kansas Cancer Center discussed their key findings and presented dozens of abstracts.
A tiny tool developed by researchers could help detect and track the spread of tumors in breast cancer patients.
Incysus Therapeutics, Inc., a biopharmaceutical company focused on delivering an gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced that the first patient in a phase I clinical study, Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide, has been treated at The University of Kansas Cancer Center.
Research arm provides COVID-19 testing for more than 500 cancer patients
Dr. Conaway has been elected for her distinguished and continuing achievements in original scientific research. Membership in the NAS is considered one of the highest honors given to a scientist in the United States.
Ronald Chen, MD, MPH, Brandmeyer Chair and Professor of Radiation Oncology, has been named the new principal investigator for NRG Oncology clinical trials efforts at The University of Kansas Cancer Center. He takes the place of Joshua Mammen, MD, PhD, FACS, division chief of Surgical Oncology, who served in the position for several years.
The distinction is given to those who have carried out efforts that benefit ASCO, the specialty of oncology and the patients they serve.
KU Cancer Center researcher participates in virtual peer-to-peer panel on expanding treatment opportunities
Researchers have identified a novel approach to overcome drug resistance in leukemia